Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...

Higher Yield for Non-Daily Symptom Patients: Non-daily symptom patients—those with symptoms occurring with a frequency less than once per day—had an 80.9% arrhythmia yield versus 69.1% in ...

Together, these findings highlight the benefits of Zio® long-term continuous monitoring (LTCM)2 and the limitations in 24–48-hour Holter monitoring still prevalent in current clinical practices ...

“They reinforce the limitations of Holter-duration monitoring and highlight the value of Zio long-term continuous monitoring up to 14 days. Once again, iRhythm's real-world data are contributing ...

Technologies announced results from two large real-world retrospective analyses presented at the American College of Cardiology, ...